anorexic patients). Despite the classification (as an SNaDRI ) amfebutamone does have an effect on serotonin levels, albeit a statistically insignificant one. The most common side effects are constipation (26% chance), weight loss (23.2% chance), nausea and/or vomiting (22.9% chance), dizziness (22.3% chance), agitation (22.2% chance) and headaches and/or migraines (22.2% chance),